Biotechne market cap
WebMarket cap: $11.9B: Data as of 3:59pm ET, 04/06/2024. Growth & Valuation. Earnings growth (last year) ... Market indices are shown in real time, except for the DJIA, which is delayed by two ... WebOur data points out that Bio-Techne Corporation (TECH) is ranked #1268 out of 13000 companies on April - 2024. TECH's Market Capitalization is $11.7 billion
Biotechne market cap
Did you know?
WebApr 13, 2024 · The stock has a market cap of $12.77 billion, a P/E ratio of 50.45, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Bio-Techne ( NASDAQ:TECH - Get Rating) last announced its quarterly earnings results on Thursday, February 2nd. The biotechnology company reported $0.38 earnings per share (EPS) for the quarter, missing … WebApr 14, 2024 · TECH opened at $83.55 on Friday. The stock has a market cap of $13.14 billion, a price-to-earnings ratio of 51.89, a PEG ratio of 2.39 and a beta of 1.25. The company has a quick ratio of 3.15, a ...
WebHolder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: 4,673,808: Sep 29, 2024: 2.97%: 353,573,582: Vanguard Small-Cap Index Fund: 3,982,452 Web24 rows · Market cap: $11.66 Billion. As of April 2024 Bio-Techne has a market cap of …
WebBased in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for ... WebMarket Cap Revenue; Medical: Medical - Biomedical and Genetics: $11.409B: $1.106B: Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and ...
WebApr 2, 2015 · Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock ...
WebMar 31, 2024 · As of March 31, 2024, BIO-TECHNE Corp had a $11.4 billion market capitalization, putting it in the 89th percentile of companies in the Biotechnology & Medical Research industry. Currently, BIO-TECHNE Corp’s price-earnings ratio is 46.2. BIO-TECHNE Corp’s trailing 12-month revenue is $1.1 billion with a 23.4% profit margin. ea play nowWebWe estimate that 12%-15% of the U.S. stock market's capitalization is comprised of SMID stocks. For our purposes, we use a threshold of $15 billion to define a SMID stock. ea play not working battlefield 2042WebApr 10, 2024 · Market Cap: 12.24B: Revenue (ttm) 1.12B: Net Income (ttm) 261.82M: Shares Out 157.28M: EPS (ttm) 1.61: PE Ratio: 47.86: Forward PE: 42.19: Dividend: … ea play nzWebApr 6, 2024 · Market Cap. Amgen Inc.-0.02 % $135.27B. Merck KGaA. 1.06 % €76.61B. Lonza Group AG ... Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American ... ea play nhl 23WebMarket cap: $11.9B: Data as of 3:59pm ET, 04/06/2024. Growth & Valuation. Earnings growth (last year) ... Market indices are shown in real time, except for the DJIA, which is … ea play not linking to xbox game passWebAbout Market Cap. As of the previous market close, Bio-Techne Corp has a market cap of $11.65B, which represents its share price of $74.06 multiplied by its outstanding shares … csr intranetWebBio-Techne Corp. TECH (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 03/24/23. $72.54USD. 0.62 0.86%. AFTER HOURS 5:33 PM EDT 03/24/23. $72.94 0.40 0.55%. AFTER … ea play offer